Horizon Investment Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.25M Sell
28,793
-2,099
-7% -$143K 0.63% 46
2026
Q1
$2M Buy
30,892
+180
+0.6% +$12.7K 0.69% 46
2025
Q4
$2.07M Buy
30,712
+422
+1% +$28.4K 0.74% 37
2025
Q3
$2.22M Buy
30,290
+3,228
+12% +$214K 0.84% 35
2025
Q2
$1.41M Buy
27,062
+12,596
+87% +$717K 0.62% 42
2025
Q1
$923K Buy
14,466
+9,707
+204% +$564K 0.45% 54
2024
Q4
$228K Sell
4,759
-23,707
-83% -$1.22M 0.1% 115
2024
Q3
$1.63M Buy
+28,466
New +$1.63M 0.7% 47

Other funds holding HALO

Horizon Investment Services's HALO Position: Q2 2026 in Review

Horizon Investment Services reduced its Halozyme (HALO) stake by 6.8% in Q2 2026, selling an estimated $143K and leaving 28,793 shares worth $2.25M. The position accounts for 0.63% of the portfolio, ranked #46.

Horizon Investment Services first reported a position in HALO in Q3 2024 and has held it in 8 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Horizon Investment Services held 28,793 shares of Halozyme worth $2.25M as of Q2 2026.
  • Horizon Investment Services sold 2,099 Halozyme shares in Q2 2026, an estimated $143K.
  • Halozyme made up 0.63% of Horizon Investment Services's portfolio in Q2 2026, its #46 holding.
  • Horizon Investment Services first reported a position in Halozyme in Q3 2024 and has held it in 8 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Horizon Investment Services's 13F filing for Q2 2026, filed 6 Aug 2026.